In the period ended 30 June 2004, Pfizer's amlodipine [Norvasc] accounted for the highest number of prescriptions in the Japanese market

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.462, 2004-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surprise over Pfizer use of ALLHAT to support amlodipine

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 408-409, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

In 2004, the number of prescriptions written and sent electronically from physicians to pharmacies reached nine million in Sweden

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The US FDA approved 31 new molecular entities in 2004, the highest number in 5 years

By  

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Major Pharmaceutical Conferences: November 2004 to June 2005

By  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 249-251

Adis International

Access to resources Recommend Favorite

Pharmaceutical & Diagnostic Conferences, June - November 2004

By  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 2, 2004-06 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite